Rituximab-induced serum sickness in progressive transformation of germinal centers immunoglobulin G4-related disease: a case report

Abstract Introduction Serum sickness, a type III hypersensitivity reaction, can arise from various triggers such as vaccines, anti-venoms, and certain medications, particularly monoclonal antibodies. Rituximab, a monoclonal antibody targeting CD20 on B-cells, is known to induce a subtype of this rea...

Full description

Bibliographic Details
Published in:Journal of Medical Case Reports
Main Authors: Sharanya Kumar, Rahul Tuli, Allen Seylani, Eric Abedi, Alexander Friedman
Format: Article
Language:English
Published: BMC 2025-04-01
Subjects:
Rituximab
RISS
IgG4-RD
Serum sickness
PTGC
Hypersensitivity
Online Access:https://doi.org/10.1186/s13256-025-05222-1

Internet

https://doi.org/10.1186/s13256-025-05222-1

Similar Items